• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本,用氨氯地平治疗患有全身性高血压的猫。

Use of amlodipine in the treatment of cats with systemic hypertension in Japan.

机构信息

Animal Emergency Medical Center, Tokyo University of Agriculture and Technology, Tokyo, Japan.

Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan.

出版信息

J Vet Med Sci. 2024 May 25;86(5):533-541. doi: 10.1292/jvms.23-0444. Epub 2024 Apr 2.

DOI:10.1292/jvms.23-0444
PMID:38569838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11144541/
Abstract

An increase in systemic blood pressure causes bleeding and ischemia owing to peripheral vascular breakdown, leading to various forms of organ damage. The brain, eyes, kidneys, and cardiovascular system are known target organs for hypertension. To our knowledge, no reports in Japan describe, in detail, the types of antihypertensive drugs used to treat hypertension in cats or its underlying causes. Therefore, we aimed to investigate the use of antihypertensive drugs in domestic cats with hypertension in Japan, the causes of hypertension, and the vital prognosis of these patients. In the present survey, we found that amlodipine was used alone (60/80 cats) or concomitantly (20/80 cats) in all cat patients with hypertension in Japan. We also determined that blood pressure measurements were not yet routinely performed on cats at veterinary clinics in Japan. Furthermore, we have new information suggesting that amlodipine administration in cats with hypertension, which lowers systolic arterial pressure levels to within the normal range (<140 mmHg), may have a negative impact on their survival. Routine blood pressure measurements for cats during their regular health checkups can help identify hypertension, and proper interpretation of blood pressure readings can facilitate suitable treatment measures.

摘要

血压升高会导致外周血管破裂出血和缺血,从而导致各种形式的器官损伤。大脑、眼睛、肾脏和心血管系统是高血压的已知靶器官。据我们所知,在日本没有详细描述用于治疗猫高血压的降压药物类型或其潜在原因的报告。因此,我们旨在调查日本患有高血压的家猫中降压药物的使用情况、高血压的病因以及这些患者的预后。在本研究中,我们发现,在日本所有患有高血压的猫患者中,氨氯地平单独使用(60/80 只猫)或联合使用(20/80 只猫)。我们还确定,在日本的兽医诊所,尚未对猫进行常规血压测量。此外,我们有新的信息表明,在患有高血压的猫中使用氨氯地平(将收缩压水平降低至正常范围内[<140mmHg])可能会对其生存产生负面影响。在常规健康检查期间对猫进行常规血压测量有助于识别高血压,并且对血压读数的正确解释有助于采取适当的治疗措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1d/11144541/194966af6f52/jvms-86-533-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1d/11144541/946a6732a71f/jvms-86-533-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1d/11144541/194966af6f52/jvms-86-533-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1d/11144541/946a6732a71f/jvms-86-533-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1d/11144541/194966af6f52/jvms-86-533-g002.jpg

相似文献

1
Use of amlodipine in the treatment of cats with systemic hypertension in Japan.在日本,用氨氯地平治疗患有全身性高血压的猫。
J Vet Med Sci. 2024 May 25;86(5):533-541. doi: 10.1292/jvms.23-0444. Epub 2024 Apr 2.
2
Treatment of systemic hypertension in cats with amlodipine besylate.用苯磺酸氨氯地平治疗猫的全身性高血压。
J Am Anim Hosp Assoc. 1997 May-Jun;33(3):226-34. doi: 10.5326/15473317-33-3-226.
3
Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats.影响高血压猫血压控制所需氨氯地平剂量与血压变化之间关系的因素。
J Vet Intern Med. 2016 Sep;30(5):1630-1636. doi: 10.1111/jvim.14562.
4
Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats.氨氯地平咀嚼片治疗家养猫高血压的随机安慰剂对照临床试验。
J Vet Intern Med. 2015 May-Jun;29(3):786-93. doi: 10.1111/jvim.12589. Epub 2015 Apr 9.
5
Effect of amlodipine on echocardiographic variables in cats with systemic hypertension.氨氯地平对全身性高血压猫超声心动图变量的影响。
J Vet Intern Med. 2001 Jan-Feb;15(1):52-6. doi: 10.1892/0891-6640(2001)015<0052:eoaoev>2.3.co;2.
6
Effect of control of systolic blood pressure on survival in cats with systemic hypertension.收缩压控制对全身性高血压猫生存的影响。
J Vet Intern Med. 2007 May-Jun;21(3):402-9. doi: 10.1892/0891-6640(2007)21[402:eocosb]2.0.co;2.
7
Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases.猫高血压:30例临床发现及抗高血压治疗反应
J Small Anim Pract. 2001 Mar;42(3):122-9. doi: 10.1111/j.1748-5827.2001.tb02008.x.
8
Concurrent disorders of cats with diabetes mellitus and arterial systolic hypertension.同时患有糖尿病和动脉收缩期高血压的猫的并发疾病。
J Feline Med Surg. 2023 Jul;25(7):1098612X231187691. doi: 10.1177/1098612X231187691.
9
[Treatment of systemic hypertension associated with kidney disease in the dog and cat].[犬猫肾病相关性系统性高血压的治疗]
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2014;42(3):194-201.
10
Treatment of feline hypertension with transdermal amlodipine: a pilot study.经皮氨氯地平治疗猫高血压的初步研究。
J Am Anim Hosp Assoc. 2007 May-Jun;43(3):149-56. doi: 10.5326/0430149.

引用本文的文献

1
Systemic Arterial Hypertension and Factors Associated with Blood Pressure Dysregulation in Companion Animals.伴侣动物的系统性动脉高血压及与血压调节异常相关的因素。
Vet Sci. 2025 May 9;12(5):453. doi: 10.3390/vetsci12050453.

本文引用的文献

1
Relationship between the lower limit of systolic blood pressure target and kidney function decline in advanced chronic kidney disease: an instrumental variable analysis from the REACH-J CKD cohort study.晚期慢性肾脏病中收缩压目标下限与肾功能下降的关系:来自 REACH-J CKD 队列研究的工具变量分析。
Hypertens Res. 2023 Nov;46(11):2478-2487. doi: 10.1038/s41440-023-01358-z. Epub 2023 Jul 18.
2
Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo.使用 SynergyFinder 3.0 和体内概率和检验评估氨氯地平和替米沙坦或坎地沙坦降压作用的协同性。
Pharmacol Res Perspect. 2023 Apr;11(2):e01064. doi: 10.1002/prp2.1064.
3
Biological variation of biochemical analytes determined at 8-week intervals for 1 year in clinically healthy cats.
对临床健康的猫进行为期1年、每隔8周测定一次的生化分析物的生物学变异。
Vet Clin Pathol. 2023 Mar;52(1):44-52. doi: 10.1111/vcp.13170. Epub 2022 Oct 26.
4
Comparative Efficacy of Antihypertensive Drugs in Dogs: A Systematic Review.犬类抗高血压药物的比较疗效:一项系统评价
Top Companion Anim Med. 2022 Sep-Oct;50:100674. doi: 10.1016/j.tcam.2022.100674. Epub 2022 May 28.
5
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.全球高血压患病率趋势及 1990 至 2019 年治疗和控制进展情况:1040 万参与者、1201 项人群代表性研究的汇总分析
Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24.
6
Hypertension in CKD: Core Curriculum 2019.慢性肾脏病中的高血压:2019 年核心课程。
Am J Kidney Dis. 2019 Jul;74(1):120-131. doi: 10.1053/j.ajkd.2018.12.044. Epub 2019 Mar 19.
7
Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.口服替米沙坦治疗猫全身性高血压的安全性和有效性:一项双盲、安慰剂对照、随机临床试验的结果。
J Vet Intern Med. 2019 Mar;33(2):478-488. doi: 10.1111/jvim.15429. Epub 2019 Mar 9.
8
Efficacy of long-term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial.长期口服替米沙坦治疗猫高血压的疗效:一项欧洲前瞻性临床试验的结果。
J Vet Intern Med. 2019 Mar;33(2):413-422. doi: 10.1111/jvim.15394. Epub 2018 Dec 18.
9
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.美国兽医内科学会共识声明:犬猫系统性高血压的识别、评估及管理指南
J Vet Intern Med. 2018 Nov;32(6):1803-1822. doi: 10.1111/jvim.15331. Epub 2018 Oct 24.
10
Antihypertensive treatment with telmisartan in a cat with amlodipine-induced gingival hyperplasia.替米沙坦治疗氨氯地平诱导的猫牙龈增生伴高血压。
JFMS Open Rep. 2017 Dec 11;3(2):2055116917745236. doi: 10.1177/2055116917745236. eCollection 2017 Jul-Dec.